Prostate cancer early detection, Version 2.2016: Featured updates to the NCCN guidelines

Peter R. Carroll; J. Kellogg Parsons; Gerald Andriole; Robert R. Bahnson; Erik P. Castle; William J. Catalona; Douglas M. Dahl; John W. Davis; Jonathan I. Epstein; Ruth B. Etzioni; Thomas Farrington; George P. Hemstreet; Mark H. Kawachi; Simon Kim; Paul H. Lange; Kevin R. Loughlin; William Lowrance; Paul Maroni; James Mohler; Todd M. Morgan; Kelvin A. Moses; Robert B. Nadler; Michael Poch; Chuck Scales; Terrence M. Shaneyfelt; Marc C. Smaldone; Geoffrey Sonn; Preston Sprenkle; Andrew J. Vickers; Robert Wake; Dorothy A. Shead; Deborah A. Freedman-Cass

doi:10.6004/jnccn.2016.0060

Prostate cancer early detection, Version 2.2016: Featured updates to the NCCN guidelines

Peter R. Carroll
, J. Kellogg Parsons
, Gerald Andriole
, Robert R. Bahnson
, Erik P. Castle
, William J. Catalona
, Douglas M. Dahl
, John W. Davis
, Jonathan I. Epstein
, Ruth B. Etzioni
, Thomas Farrington
, George P. Hemstreet
, Mark H. Kawachi
, Simon Kim
, Paul H. Lange
, Kevin R. Loughlin
, William Lowrance
, Paul Maroni
, James Mohler
, Todd M. Morgan

Kelvin A. Moses, Robert B. Nadler, Michael Poch, Chuck Scales, Terrence M. Shaneyfelt, Marc C. Smaldone, Geoffrey Sonn, Preston Sprenkle, Andrew J. Vickers, Robert Wake, Dorothy A. Shead, Deborah A. Freedman-Cass

Department of Urology

University of California at San Francisco
University of California at San Diego
Washington University St. Louis
Ohio State University
Mayo Clinic Rochester, MN
Northwestern University
Massachusetts General Hospital Cancer Center
University of Texas MD Anderson Cancer Center
Johns Hopkins University
Seattle Cancer Care Alliance
Prostate Health Education Network
Nebraska Medicine
Hope Comprehensive Cancer Center
Case Western Reserve University
University of Washington
Dana-Farber/Brigham and Women's Cancer Center
University of Utah
University of Colorado Anschutz Medical Campus
University of Michigan, Ann Arbor
Vanderbilt University
Moffitt Cancer Center
Duke University
University of Alabama at Birmingham
Fox Chase Cancer Center
Stanford University
Yale University
Memorial Sloan-Kettering Cancer Center
University of Tennessee Health Science Center
National Comprehensive Cancer Network

Research output: Contribution to journal › Review article › peer-review

279 Scopus citations

Abstract

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer Early Detection provide recommendations for prostate cancer screening in healthy men who have elected to participate in an early detection program. The NCCN Guidelines focus on minimizing unnecessary procedures and limiting the detection of indolent disease. These NCCN Guidelines Insights summarize the NCCN Prostate Cancer Early Detection Panel's most significant discussions for the 2016 guideline update, which included issues surrounding screening in high-risk populations (ie, African Americans, BRCA1/2 mutation carriers), approaches to refine patient selection for initial and repeat biopsies, and approaches to improve biopsy specificity.

Original language	English
Pages (from-to)	509-519
Number of pages	11
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	14
Issue number	5
DOIs	https://doi.org/10.6004/jnccn.2016.0060
State	Published - May 1 2016

Access to Document

10.6004/jnccn.2016.0060

Cite this

Carroll, P. R., Parsons, J. K., Andriole, G., Bahnson, R. R., Castle, E. P., Catalona, W. J., Dahl, D. M., Davis, J. W., Epstein, J. I., Etzioni, R. B., Farrington, T., Hemstreet, G. P., Kawachi, M. H., Kim, S., Lange, P. H., Loughlin, K. R., Lowrance, W., Maroni, P., Mohler, J., ... Freedman-Cass, D. A. (2016). Prostate cancer early detection, Version 2.2016: Featured updates to the NCCN guidelines. JNCCN Journal of the National Comprehensive Cancer Network, 14(5), 509-519. https://doi.org/10.6004/jnccn.2016.0060

@article{15e4ac11aac64731a70d1a2ba124906e,

title = "Prostate cancer early detection, Version 2.2016: Featured updates to the NCCN guidelines",

abstract = "The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer Early Detection provide recommendations for prostate cancer screening in healthy men who have elected to participate in an early detection program. The NCCN Guidelines focus on minimizing unnecessary procedures and limiting the detection of indolent disease. These NCCN Guidelines Insights summarize the NCCN Prostate Cancer Early Detection Panel's most significant discussions for the 2016 guideline update, which included issues surrounding screening in high-risk populations (ie, African Americans, BRCA1/2 mutation carriers), approaches to refine patient selection for initial and repeat biopsies, and approaches to improve biopsy specificity.",

author = "Carroll, \{Peter R.\} and Parsons, \{J. Kellogg\} and Gerald Andriole and Bahnson, \{Robert R.\} and Castle, \{Erik P.\} and Catalona, \{William J.\} and Dahl, \{Douglas M.\} and Davis, \{John W.\} and Epstein, \{Jonathan I.\} and Etzioni, \{Ruth B.\} and Thomas Farrington and Hemstreet, \{George P.\} and Kawachi, \{Mark H.\} and Simon Kim and Lange, \{Paul H.\} and Loughlin, \{Kevin R.\} and William Lowrance and Paul Maroni and James Mohler and Morgan, \{Todd M.\} and Moses, \{Kelvin A.\} and Nadler, \{Robert B.\} and Michael Poch and Chuck Scales and Shaneyfelt, \{Terrence M.\} and Smaldone, \{Marc C.\} and Geoffrey Sonn and Preston Sprenkle and Vickers, \{Andrew J.\} and Robert Wake and Shead, \{Dorothy A.\} and Freedman-Cass, \{Deborah A.\}",

note = "Publisher Copyright: {\textcopyright} JNCCN-Journal of tha National Comprehensive Cancer Network.",

year = "2016",

month = may,

day = "1",

doi = "10.6004/jnccn.2016.0060",

language = "English",

volume = "14",

pages = "509--519",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Harborside Press",

number = "5",

}

Carroll, PR, Parsons, JK, Andriole, G, Bahnson, RR, Castle, EP, Catalona, WJ, Dahl, DM, Davis, JW, Epstein, JI, Etzioni, RB, Farrington, T, Hemstreet, GP, Kawachi, MH, Kim, S, Lange, PH, Loughlin, KR, Lowrance, W, Maroni, P, Mohler, J, Morgan, TM, Moses, KA, Nadler, RB, Poch, M, Scales, C, Shaneyfelt, TM, Smaldone, MC, Sonn, G, Sprenkle, P, Vickers, AJ, Wake, R, Shead, DA & Freedman-Cass, DA 2016, 'Prostate cancer early detection, Version 2.2016: Featured updates to the NCCN guidelines', JNCCN Journal of the National Comprehensive Cancer Network, vol. 14, no. 5, pp. 509-519. https://doi.org/10.6004/jnccn.2016.0060

TY - JOUR

T1 - Prostate cancer early detection, Version 2.2016

T2 - Featured updates to the NCCN guidelines

AU - Carroll, Peter R.

AU - Parsons, J. Kellogg

AU - Andriole, Gerald

AU - Bahnson, Robert R.

AU - Castle, Erik P.

AU - Catalona, William J.

AU - Dahl, Douglas M.

AU - Davis, John W.

AU - Epstein, Jonathan I.

AU - Etzioni, Ruth B.

AU - Farrington, Thomas

AU - Hemstreet, George P.

AU - Kawachi, Mark H.

AU - Kim, Simon

AU - Lange, Paul H.

AU - Loughlin, Kevin R.

AU - Lowrance, William

AU - Maroni, Paul

AU - Mohler, James

AU - Morgan, Todd M.

AU - Moses, Kelvin A.

AU - Nadler, Robert B.

AU - Poch, Michael

AU - Scales, Chuck

AU - Shaneyfelt, Terrence M.

AU - Smaldone, Marc C.

AU - Sonn, Geoffrey

AU - Sprenkle, Preston

AU - Vickers, Andrew J.

AU - Wake, Robert

AU - Shead, Dorothy A.

AU - Freedman-Cass, Deborah A.

PY - 2016/5/1

Y1 - 2016/5/1

N2 - The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer Early Detection provide recommendations for prostate cancer screening in healthy men who have elected to participate in an early detection program. The NCCN Guidelines focus on minimizing unnecessary procedures and limiting the detection of indolent disease. These NCCN Guidelines Insights summarize the NCCN Prostate Cancer Early Detection Panel's most significant discussions for the 2016 guideline update, which included issues surrounding screening in high-risk populations (ie, African Americans, BRCA1/2 mutation carriers), approaches to refine patient selection for initial and repeat biopsies, and approaches to improve biopsy specificity.

AB - The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer Early Detection provide recommendations for prostate cancer screening in healthy men who have elected to participate in an early detection program. The NCCN Guidelines focus on minimizing unnecessary procedures and limiting the detection of indolent disease. These NCCN Guidelines Insights summarize the NCCN Prostate Cancer Early Detection Panel's most significant discussions for the 2016 guideline update, which included issues surrounding screening in high-risk populations (ie, African Americans, BRCA1/2 mutation carriers), approaches to refine patient selection for initial and repeat biopsies, and approaches to improve biopsy specificity.

UR - https://www.scopus.com/pages/publications/84968764427

U2 - 10.6004/jnccn.2016.0060

DO - 10.6004/jnccn.2016.0060

M3 - Review article

C2 - 27160230

AN - SCOPUS:84968764427

SN - 1540-1405

VL - 14

SP - 509

EP - 519

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 5

ER -

Prostate cancer early detection, Version 2.2016: Featured updates to the NCCN guidelines

Abstract

Access to Document

Other files and links

Fingerprint

Cite this